Form 4: Tenet Healthcare Director Receives Equity Grant

Director James L. Bierman was granted 1,188 restricted stock units as part of Tenet Healthcare's incentive plan.

Summary

• Director James L. Bierman received a grant of 1,188 restricted stock units (RSUs) on May 27, 2026.
• Each RSU represents the economic equivalent of one share of Tenet Healthcare common stock.
• The units are scheduled to vest on May 27, 2027, one year after the grant date.
• The reporting person has the option to receive up to 37% of the vested units in cash rather than shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding standard director compensation.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified; this is a standard compensatory equity grant.

Risks

• None identified; this is a standard compensatory equity grant.

Future Outlook

The restricted stock units will vest on May 27, 2027, at which point the director will receive shares or a cash equivalent for up to 37% of the grant.

Industry Context

StockSavvy.ai notes that equity grants to board members are a standard corporate governance practice in the healthcare sector to ensure directors maintain a vested interest in the company's long-term performance.

Comparison to Industry Standards

• The grant of restricted stock units is consistent with standard executive and director compensation packages among large-cap healthcare providers.
• The one-year vesting schedule is typical for non-employee director equity awards.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine equity grant to a director.

Next Steps

• Vesting of the 1,188 restricted stock units on May 27, 2027.

Key Dates

Keywords

Tenet Healthcare, THC, Form 4, Insider Trading, Equity Compensation, Director Compensation